North America Deep Brain Stimulation Devices Market By Applications (Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications) By End User (Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others) By Country, Industry Analysis and Forecast, 2019 - 2025
The North America Deep Brain Stimulation Devices Market would witness market growth of 15.4% CAGR during the forecast period (2019-2025).
Several commercially available electrodes are capable of delivering directional current, and require adjustments to a particular targeted area. This advancement helps refine the stimulation paradigms and avoid unwanted DBS side effects. Additionally, while most DBS systems include a constant train of electrical stimulations, there is increasing interest in closed-loop DBS in which stimulation is turned on the basis of detecting the presence of a pathological physiological signal. Some of the signals might include the occurrence of an electroencephalographic abnormality in patients with epilepsy43 or the increase in oscillatory activity in patients with PD.
In the United States alone, the total direct and indirect costs of Parkinson's in the United States have determined costs equivalent to billions of dollars that include treatment, disability, and related expenses, along with the lost income due to the inability of the patients to work. This has prompted the original equipment manufacturers (OEMs) to build cost-effective tools for the treatment of neurological movement disorders, combined with unpredictable economic conditions in the United States. In 2015, the US Food and Drug Administration (FDA) approved deep brain stimulation (DBS) system to treat Parkinson's disease and essential tremor, called Brio System.
Based on Application, the market is segmented into Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy and Others. Based on End Use, the market is segmented into Diagnostic Centers, Clinics and Hospitals. Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Scope of the Study
Market Segmentation:
By Application
Several commercially available electrodes are capable of delivering directional current, and require adjustments to a particular targeted area. This advancement helps refine the stimulation paradigms and avoid unwanted DBS side effects. Additionally, while most DBS systems include a constant train of electrical stimulations, there is increasing interest in closed-loop DBS in which stimulation is turned on the basis of detecting the presence of a pathological physiological signal. Some of the signals might include the occurrence of an electroencephalographic abnormality in patients with epilepsy43 or the increase in oscillatory activity in patients with PD.
In the United States alone, the total direct and indirect costs of Parkinson's in the United States have determined costs equivalent to billions of dollars that include treatment, disability, and related expenses, along with the lost income due to the inability of the patients to work. This has prompted the original equipment manufacturers (OEMs) to build cost-effective tools for the treatment of neurological movement disorders, combined with unpredictable economic conditions in the United States. In 2015, the US Food and Drug Administration (FDA) approved deep brain stimulation (DBS) system to treat Parkinson's disease and essential tremor, called Brio System.
Based on Application, the market is segmented into Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy and Others. Based on End Use, the market is segmented into Diagnostic Centers, Clinics and Hospitals. Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Scope of the Study
Market Segmentation:
By Application
- Bronchoscopy
- GI endoscopy
- ENT Endoscopy
- Urologic endoscopy
- Arthroscopy and
- Others
- Diagnostic Centers
- Clinics and
- Hospitals
- Parkinson's disease
- Epilepsy
- Essential Tremor
- Dystonia
- Obsessive Compulsive Disorder and
- Other Applications
- Neurological Clinics
- Ambulatory Surgical Centers
- Hospital and
- Others
- US
- Canada
- Mexico
- Rest of North America
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Functional Neuromodulation, Ltd.
- Beijing PINS Medical Co., Ltd.
- NeuroPace, Inc.
- Nevro Corporation
- Neuronetics, Inc.
- Fisher Wallace Laboratories, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Deep Brain Stimulation Devices Market, by Applications
1.4.2 North America Deep Brain Stimulation Devices Market, by End User
1.4.3 North America Deep Brain Stimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS
3.1 North America Parkinson's Disease Market by Country
3.2 North America Epilepsy Market by Country
3.3 North America Essential Tremor Market by Country
3.4 North America Dystonia Market by Country
3.5 North America Obsessive Compulsive Disorder Market by Country
3.6 North America Others Market by Country
CHAPTER 4. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS
4.1 North America Neurological Clinics Market by Country
4.2 North America Ambulatory Surgical Centers Market by Country
4.3 North America Hospital Market by Country
4.4 North America Others Market by Country
CHAPTER 5. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY COUNTRY
5.1 USA Deep Brain Stimulation Devices Market
5.1.1 USA Deep Brain Stimulation Devices Market by Applications
5.1.2 USA Deep Brain Stimulation Devices Market by End Users
5.2 Canada Deep Brain Stimulation Devices Market
5.2.1 Canada Deep Brain Stimulation Devices Market by Applications
5.2.2 Canada Deep Brain Stimulation Devices Market by End Users
5.3 Mexico Deep Brain Stimulation Devices Market
5.3.1 Mexico Deep Brain Stimulation Devices Market by Applications
5.3.2 Mexico Deep Brain Stimulation Devices Market by End Users
5.4 Rest of North America Deep Brain Stimulation Devices Market
5.4.1 Rest of North America Deep Brain Stimulation Devices Market by Applications
5.4.2 Rest of North America Deep Brain Stimulation Devices Market by End Users
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Approvals:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.1 Recent strategies and developments:
6.2.1.1 Approvals:
6.2.1.2 Product Launches and Product Expansions:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.4 Aleva Neurotherapeutics SA
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Partnerships, Collaborations, and Agreements:
6.4.2.2 Approvals:
6.5 Functional Neuromodulation Ltd.
6.5.1 Company Overview
6.6 Beijing PINS Medical Co., Ltd.
6.6.1 Company Overview
6.7 NeuroPace, Inc.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Product Launches and Product Expansions:
6.8 Nevro Corporation
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 Neuronetics, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Partnerships, Collaborations, and Agreements:
6.1 Fisher Wallace Laboratories, Inc.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Deep Brain Stimulation Devices Market, by Applications
1.4.2 North America Deep Brain Stimulation Devices Market, by End User
1.4.3 North America Deep Brain Stimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS
3.1 North America Parkinson's Disease Market by Country
3.2 North America Epilepsy Market by Country
3.3 North America Essential Tremor Market by Country
3.4 North America Dystonia Market by Country
3.5 North America Obsessive Compulsive Disorder Market by Country
3.6 North America Others Market by Country
CHAPTER 4. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS
4.1 North America Neurological Clinics Market by Country
4.2 North America Ambulatory Surgical Centers Market by Country
4.3 North America Hospital Market by Country
4.4 North America Others Market by Country
CHAPTER 5. NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY COUNTRY
5.1 USA Deep Brain Stimulation Devices Market
5.1.1 USA Deep Brain Stimulation Devices Market by Applications
5.1.2 USA Deep Brain Stimulation Devices Market by End Users
5.2 Canada Deep Brain Stimulation Devices Market
5.2.1 Canada Deep Brain Stimulation Devices Market by Applications
5.2.2 Canada Deep Brain Stimulation Devices Market by End Users
5.3 Mexico Deep Brain Stimulation Devices Market
5.3.1 Mexico Deep Brain Stimulation Devices Market by Applications
5.3.2 Mexico Deep Brain Stimulation Devices Market by End Users
5.4 Rest of North America Deep Brain Stimulation Devices Market
5.4.1 Rest of North America Deep Brain Stimulation Devices Market by Applications
5.4.2 Rest of North America Deep Brain Stimulation Devices Market by End Users
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Approvals:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.1 Recent strategies and developments:
6.2.1.1 Approvals:
6.2.1.2 Product Launches and Product Expansions:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.4 Aleva Neurotherapeutics SA
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Partnerships, Collaborations, and Agreements:
6.4.2.2 Approvals:
6.5 Functional Neuromodulation Ltd.
6.5.1 Company Overview
6.6 Beijing PINS Medical Co., Ltd.
6.6.1 Company Overview
6.7 NeuroPace, Inc.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Product Launches and Product Expansions:
6.8 Nevro Corporation
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 Neuronetics, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Partnerships, Collaborations, and Agreements:
6.1 Fisher Wallace Laboratories, Inc.
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA ESSENTIAL TREMOR MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA ESSENTIAL TREMOR MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA DYSTONIA MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA DYSTONIA MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA OBSESSIVE COMPULSIVE DISORDER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA OBSESSIVE COMPULSIVE DISORDER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA NEUROLOGICAL CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA NEUROLOGICAL CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 USA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 30 USA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 31 USA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 32 USA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 33 USA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 34 USA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 35 CANADA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 36 CANADA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 37 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 38 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 39 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 40 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 41 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 42 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 43 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 44 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 45 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 46 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 47 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 48 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 49 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 50 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 51 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 52 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 53 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 54 KEY INFORMATION – MEDTRONIC PLC
TABLE 55 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 56 KEY INFORMATION – ALEVA NEUROTHERAPEUTICS SA
TABLE 57 KEY INFORMATION – FUNCTIONAL NEUROMODULATION LTD.
TABLE 58 KEY INFORMATION – BEIJING PINS MEDICAL CO., LTD.
TABLE 59 KEY INFORMATION – NEUROPACE, INC.
TABLE 60 KEY INFORMATION – NEVRO CORPORATION
TABLE 61 KEY INFORMATION – NEURONETICS, INC.
TABLE 62 KEY INFORMATION –FISHER WALLACE LABORATORIES, INC.
TABLE 1 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA ESSENTIAL TREMOR MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA ESSENTIAL TREMOR MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA DYSTONIA MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA DYSTONIA MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA OBSESSIVE COMPULSIVE DISORDER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA OBSESSIVE COMPULSIVE DISORDER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA NEUROLOGICAL CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA NEUROLOGICAL CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 USA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 30 USA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 31 USA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 32 USA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 33 USA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 34 USA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 35 CANADA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 36 CANADA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 37 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 38 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 39 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 40 CANADA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 41 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 42 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 43 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 44 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 45 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 46 MEXICO DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 47 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 48 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 49 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 50 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 51 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2015 - 2018, USD MILLION
TABLE 52 REST OF NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET BY END USERS, 2019 - 2025, USD MILLION
TABLE 53 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 54 KEY INFORMATION – MEDTRONIC PLC
TABLE 55 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 56 KEY INFORMATION – ALEVA NEUROTHERAPEUTICS SA
TABLE 57 KEY INFORMATION – FUNCTIONAL NEUROMODULATION LTD.
TABLE 58 KEY INFORMATION – BEIJING PINS MEDICAL CO., LTD.
TABLE 59 KEY INFORMATION – NEUROPACE, INC.
TABLE 60 KEY INFORMATION – NEVRO CORPORATION
TABLE 61 KEY INFORMATION – NEURONETICS, INC.
TABLE 62 KEY INFORMATION –FISHER WALLACE LABORATORIES, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
